Literature DB >> 8016110

Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.

J K Westwick1, A D Cox, C J Der, M H Cobb, M Hibi, M Karin, D A Brenner.   

Abstract

c-Jun transcriptional activity is augmented by expression of oncogenic Ras and Raf proteins. This study demonstrates a direct correlation between Ras transforming activity and c-Jun activation, supporting an important role for c-Jun in transformation by Ras. Since we observed that Ras activated c-Jun transcriptional activity by increasing phosphorylation of the c-Jun activation domain at residues Ser-63/Ser-73 and that oncogenic Ras proteins activated extracellular signal-regulated protein kinases (ERK1 and ERK2) (also known as mitogen-activated protein kinases), we evaluated the possibility that ERKs were directly responsible for c-Jun activation. Coexpression of wild-type ERKs with oncogenic Ras proteins potentiated, while kinase-defective ERKs inhibited, Ras-induced transcriptional activation from the Ras-responsive element (Ets-1/AP-1) present in the NVL-3 enhancer and the serum-response element in the c-fos promoter. In contrast, coexpression of either wild-type or kinase-defective ERKs inhibited Ras and Raf activation of c-Jun transcriptional activity. Thus, although activation of both ERK and c-Jun are downstream consequences of activation of the Ras signal transduction pathway, our results suggest that Ras-induced c-Jun phosphorylation and transcriptional activation are not a direct consequence of ERK1 and ERK2 activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016110      PMCID: PMC44131          DOI: 10.1073/pnas.91.13.6030

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  DNA-mediated gene transfer into adult rat hepatocytes in primary culture.

Authors:  R A Rippe; D A Brenner; H L Leffert
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 2.  The GTPase superfamily: a conserved switch for diverse cell functions.

Authors:  H R Bourne; D A Sanders; F McCormick
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

3.  Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal.

Authors:  J E Buss; P A Solski; J P Schaeffer; M J MacDonald; C J Der
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

4.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.

Authors:  W J Boyle; T Smeal; L H Defize; P Angel; J R Woodgett; M Karin; T Hunter
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

5.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.

Authors:  B Binétruy; T Smeal; M Karin
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

6.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis.

Authors:  V P Stanton; D W Nichols; A P Laudano; G M Cooper
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

Review 7.  Proteins regulating Ras and its relatives.

Authors:  M S Boguski; F McCormick
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

Review 8.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

9.  ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun.

Authors:  P Sassone-Corsi; C J Der; I M Verma
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

10.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells.

Authors:  W Kolch; G Heidecker; P Lloyd; U R Rapp
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

View more
  48 in total

1.  Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture.

Authors:  T Knittel; D Kobold; J Dudas; B Saile; G Ramadori
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 3.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

4.  Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase.

Authors:  Li-Jin Chew; William Coley; Ying Cheng; Vittorio Gallo
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

5.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.

Authors:  R Khosravi-Far; M A White; J K Westwick; P A Solski; M Chrzanowska-Wodnicka; L Van Aelst; M H Wigler; C J Der
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

7.  Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter.

Authors:  M Faris; K M Latinis; S J Kempiak; G A Koretzky; A Nel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Complexes of p21RAS with JUN N-terminal kinase and JUN proteins.

Authors:  V Adler; M R Pincus; P W Brandt-Rauf; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

Review 9.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

10.  The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.

Authors:  L Folgueira; A Algeciras; W S MacMorran; G D Bren; C V Paya
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.